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Background: There is evidence that platelet hyper-reactivity mediates peri- and post-procedural ischemic events in patients undergoing 
percutaneous coronary intervention (PCI). The procedure itself has been shown to enhance platelet aggregation. Contemporary periprocedural dual 
antiplatelet therapy (DAPT) focuses primarily on the effects of arachidonic acid and adenosine-5’-diphosphate (ADP). PCI, however, leads to elevated 
levels of 8-isoprostane, an indicator of ischemia-induced oxidative stress, and also to the exposure of collagen, resulting from vascular endothelial 
injury that occurs during stent deployment. The purpose of this study was to investigate the role of other factors in the enhancement of platelet 
aggregability during PCI.
Methods: We studied platelet aggregation in 21 patients, mean age 59 years, who were undergoing coronary stenting and had been pretreated 
with aspirin and also received a 600 mg dose of clopidogrel prior to the procedure. Platelet aggregation responses to collagen (COL) and 8-iso-
prostaglandin F2 alpha (8-isoprostane) as well as ADP, epinephrine (EPI) and arachidonic acid (AA) were assessed immediately before, during and 6 
hours after PCI by optical aggregometry (PICA, Model 600, Chrono-Log Corp., Havertown, PA).
Results: This study confirmed that patients had enhanced platelet reactivity at the time of admission and that the PCI procedure itself increased 
platelet aggregability. While clopidogrel and aspirin decreased the platelet response to ADP (by 30%; p<0.001) and AA (by 28%, p=0.147), treatment 
with clopidogrel and aspirin showed no effect on COL and 8-isoprostane. Six hours after PCI, platelets aggregability increased by 24.07% (p<0.05) in 
response to COL, and by 46.72% (p<0.001) in response to 8-isoprostane.
Conclusion: DAPT incompletely inhibits platelet aggregatory response to ADP and arachidonic acid and has no effect on collagen and 
8-isoprostane. The residual platelet hyper-reactivity may play a significant role in the ischemic outcome following PCI.
